349 related articles for article (PubMed ID: 28324284)
1. Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal.
Sammour T; Price BA; Krause KJ; Chang GJ
Ann Surg Oncol; 2017 Jul; 24(7):1904-1915. PubMed ID: 28324284
[TBL] [Abstract][Full Text] [Related]
2. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
3. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
[No Abstract] [Full Text] [Related]
4. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
[TBL] [Abstract][Full Text] [Related]
5. Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years.
Strode M; Shah R; Boland PM; Francescutti VA; Mangieri CW; Attwood K; Nurkin SJ
Surg Oncol; 2019 Mar; 28():116-120. PubMed ID: 30851884
[TBL] [Abstract][Full Text] [Related]
6. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
[TBL] [Abstract][Full Text] [Related]
7. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
Dossa F; Chesney TR; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
[TBL] [Abstract][Full Text] [Related]
8. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
9. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
Kong JC; Guerra GR; Warrier SK; Ramsay RG; Heriot AG
Dis Colon Rectum; 2017 Mar; 60(3):335-345. PubMed ID: 28177997
[TBL] [Abstract][Full Text] [Related]
10. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
11. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
[TBL] [Abstract][Full Text] [Related]
12. Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Li J; Li L; Yang L; Yuan J; Lv B; Yao Y; Xing S
Oncotarget; 2016 Jul; 7(28):44857-44870. PubMed ID: 27070085
[TBL] [Abstract][Full Text] [Related]
13. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
[TBL] [Abstract][Full Text] [Related]
14. Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study.
Araujo RO; Valadão M; Borges D; Linhares E; de Jesus JP; Ferreira CG; Victorino AP; Vieira FM; Albagli R
Eur J Surg Oncol; 2015 Nov; 41(11):1456-63. PubMed ID: 26362228
[TBL] [Abstract][Full Text] [Related]
15. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
[TBL] [Abstract][Full Text] [Related]
16. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?
Habr-Gama A; Sabbaga J; Gama-Rodrigues J; São Julião GP; Proscurshim I; Bailão Aguilar P; Nadalin W; Perez RO
Dis Colon Rectum; 2013 Oct; 56(10):1109-17. PubMed ID: 24022527
[TBL] [Abstract][Full Text] [Related]
17. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
[TBL] [Abstract][Full Text] [Related]
18. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
Chadi SA; Malcomson L; Ensor J; Riley RD; Vaccaro CA; Rossi GL; Daniels IR; Smart NJ; Osborne ME; Beets GL; Maas M; Bitterman DS; Du K; Gollins S; Sun Myint A; Smith FM; Saunders MP; Scott N; O'Dwyer ST; de Castro Araujo RO; Valadao M; Lopes A; Hsiao CW; Lai CL; Smith RK; Paulson EC; Appelt A; Jakobsen A; Wexner SD; Habr-Gama A; Sao Julião G; Perez R; Renehan AG
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):825-836. PubMed ID: 30318451
[TBL] [Abstract][Full Text] [Related]
20. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]